TELA Bio (TELA) EBIT Margin Growth (3y) (2021 - 2026)
Powered by 
Analysis
TELA Bio (TELA) EBIT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | 244.00 |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn | 2,337.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,337.00 |
| Mar 31, 2026 | 3,927.00 |
| Dec 31, 2025 | 4,936.00 |
| Sep 30, 2025 | 4,850.00 |
| Jun 30, 2025 | 5,341.00 |
| Mar 31, 2025 | 6,305.00 |
| Dec 31, 2024 | 4,407.00 |
| Sep 30, 2024 | 4,489.00 |
| Jun 30, 2024 | 2,483.00 |
| Mar 31, 2024 | 9,462.00 |
| Dec 31, 2023 | 4,683.00 |
| Sep 30, 2023 | 6,153.00 |
| Jun 30, 2023 | 7,581.00 |
| Mar 31, 2023 | 7,992.00 |
| Dec 31, 2022 | 3,856.00 |
| Sep 30, 2022 | 1,204.00 |
| Jun 30, 2022 | 3,181.00 |
| Mar 31, 2022 | 3,709.00 |
| Dec 31, 2021 | 13,513.00 |
| Sep 30, 2021 | 1,981.00 |